Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment
Research output: Contribution to journal › Article › peer-review
13Citations
(Scopus)
39Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment'. Together they form a unique fingerprint.